ArticleClinical and translational science2026

Interleukin-40 in Systemic Sclerosis: A Treatment-Sensitive Marker of Immune Modulation Rather Than Disease Activity.

İbrahim Vasi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.